WhaleCreep

Which hedge funds own BLU? BELLUS HEALTH INC NEW, Q2 2026 13F holders

0 tracked hedge funds disclosed a position in BLU (BELLUS HEALTH INC NEW) in their Q2 2026 13F filings, worth $0 in total.

0
Holders
0
New this quarter
0
Exited this quarter
$0
Combined value
–
Share of managers holding

Holders, Q2 2026

0 rows

Ownership over time

By quarter
QuarterHoldersManagers filingShare holdingCombined value
Q2 20230730.0%$0
Q1 20234735.5%$127m
Q4 20224735.5%$144m
Q3 20224745.4%$171m
Q2 20224745.4%$136m
Q1 20223744.1%$97.2m
Q4 20213744.1%$113m
Q3 20212712.8%$31.1m
Q2 20212712.8%$27.6m
Q1 20212702.9%$48.4m
Q4 20204715.6%$41.4m
Q3 20201681.5%$547k
Q2 20203684.4%$6.7m
Q1 20201681.5%$597k
Q4 20191671.5%$627k
Q3 20192603.3%$504k

Who discovered BLU first?

Earliest meaningful positions among the 7 tracked managers seen opening BLU since Q3 2019.

2 rows
RA Capital Management, L.P.Q4 20211.5%2.6%6Exited by Q2 2023−11%
Avidity Partners Management LPQ4 20200.6%1.1%10Exited by Q2 2023+18%

Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.